Horizon CEO, Joel White, spoke with BioSpace about what a Trump presidency could mean for the Inflation Reduction Act (IRA).
Joel White, a Republican healthcare strategist, told BioSpace that the bureaucracy surrounding the IRA is complicated and not transparent, and he sees the potential for Trump to fire all those CMS staff involved in the Medicare Drug Price Negotiation Program and give savings directly to U.S. consumers without the federal negotiations process under the law. He contends that a new administration could install a premium mitigation strategy to provide some form of relief to consumers.
“All these new bureaucrats (have) gone through these hoops and hurdles, where we could just really just, for these older products, get discounts directly to the consumer much more visible,” White said.